Upendra Parvathaneni
Overview
Explore the profile of Upendra Parvathaneni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takayesu J, Parvathaneni U, Laramore G, Panjwani N, Sillings J, Futran N, et al.
Cancer Rep (Hoboken)
. 2025 Feb;
8(2):e70111.
PMID: 39907094
Background: Head and neck mucosal melanoma (HNMM) is rare and carries a poor prognosis with high rates of disease progression. There is little data regarding the use of adjuvant proton...
2.
Wallner K, Kearney K, Azzalini L, Kim E, Parvathaneni U, Sandison G, et al.
Brachytherapy
. 2024 Dec;
24(1):103-109.
PMID: 39658407
Introduction: There is some evidence of a dose-response relationship for intravascular brachytherapy (IVBT) of native vessel or first-time in-stent restenosis (ISR). It has also been shown that in-field failure predominates...
3.
Pan C, Ng K, Voutsinas J, Barber B, Rizvi Z, Marchiano E, et al.
BMC Cancer
. 2024 Nov;
24(1):1406.
PMID: 39543541
Background: We previously reported in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs), pretreatment higher lactate dehydrogenase (LDH) and absolute (abx) neutrophils as...
4.
Bierma M, Goff P, Hippe D, Lachance K, Schaub S, Wallner K, et al.
Adv Radiat Oncol
. 2024 Jan;
9(2):101364.
PMID: 38189056
Purpose: The role of postoperative radiation therapy (PORT) in early stage Merkel cell carcinoma (MCC) is controversial. We analyzed the role of PORT in preventing local recurrences (LR) among patients...
5.
Moffitt G, Sandison G, Argento D, Emery R, Wootton L, Parvathaneni U, et al.
Phys Med Biol
. 2023 Nov;
68(24).
PMID: 37983905
Fast neutron therapy is a high linear energy transfer (LET) radiation treatment modality offering advantages over low LET radiations. Multileaf collimator technology reduces normal-tissue dose (toxicity) and makes neutron therapy...
6.
Alexander N, Schaub S, Goff P, Hippe D, Park S, Lachance K, et al.
J Am Acad Dermatol
. 2023 Oct;
90(2):261-268.
PMID: 37778663
Background: Merkel cell carcinoma (MCC) is often treated with surgery and postoperative radiation therapy (PORT). The optimal time to initiate PORT (Time-to-PORT [ttPORT]) is unknown. Purpose: We assessed if delays...
7.
Gobillot T, Greer M, Parvathaneni U, Liao J, Laramore G, Goff P, et al.
Head Neck
. 2023 Jul;
45(9):2323-2334.
PMID: 37448346
Background: Perineural invasion (PNI) in head and neck squamous cell carcinoma (HNSCC) portends poor prognosis. Extent of treatment of nerve pathways with varying degrees of PNI and patterns of failure...
8.
Singh N, McClure E, Doolittle-Amieva C, Parvathaneni U, Bhatia S, Moshiri A
JAAD Case Rep
. 2023 Jun;
36:15-17.
PMID: 37361404
No abstract available.
9.
Lussier L, Wallner K, Kearney K, Tiwana J, Kim E, Parvathaneni U, et al.
Brachytherapy
. 2023 May;
22(4):518-523.
PMID: 37211487
Purpose: Coronary stents reduce IVBT radiation dose with a single layer by 10-30%. However, the impact of multiple stent layers and stent expansion remains unexplored. Individualized dose adjustments considering variations...
10.
Pan C, Wu Q, Voutsinas J, Houlton J, Barber B, Rizvi Z, et al.
Cancer Med
. 2023 Feb;
12(8):9384-9391.
PMID: 36806947
Background: Little is known regarding associations between peripheral blood biomarkers (PBBMs) and survival, response, and toxicity in recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) treated with immune checkpoint...